Komodo Health

Overview

Komodo Health is a healthcare artificial intelligence company headquartered in New York City at 257 Park Ave South, 2nd Floor[1][10]. Founded in 2014[8], the company is led by co-founder and CEO Arif Nathoo, MD, with co-founder Web Sun serving as President[8].

The company provides healthcare AI and real-world data analytics to life sciences companies, providers, payers, financial services firms and consultancies[3]. Its Healthcare Map platform contains more than 1 trillion linked records covering 330 million de-identified patients, refreshed daily[4]. Komodo Health also operates Marmot, an AI intelligence layer that produces reproducible, auditable insights and ships apps and agents for workflow management[5]. The company states its AI has been validated across more than 1 million real analyses and holds CMS Qualified Entity status[7]. Named customers include Alnylam Pharmaceuticals, Argenx, Merck and Novo Nordisk[6]. In March 2021, Komodo Health raised $220 million in Series E funding led by Tiger Global Management[9].

Headquarters in New York City at 257 Park Ave South, 2nd Floor, New York, NY 10010 [1]

Komodo Health's Healthcare Map contains more than 1 trillion linked records covering 330M+ de-identified patients, refreshed daily. [4]

Komodo Health's Marmot is an AI intelligence layer that produces reproducible, auditable insights and ships apps and agents for workflow management. [5]

Komodo Health was founded in 2014; co-founder Arif Nathoo, MD is CEO and co-founder Web Sun is President. [8]

Komodo Health's New York office is at 257 Park Ave South, 2nd Floor, New York, NY 10010, alongside offices in San Francisco, Los Altos, Chicago and Chennai. [10]

Customers

Komodo Health names Alnylam Pharmaceuticals, Argenx, Merck and Novo Nordisk as customers. [6]

Growth & traction

Komodo Health states its AI has been validated across more than 1 million real analyses, and that it is a CMS Qualified Entity. [7]

Funding history

Komodo Health announced on March 22, 2021 that it had raised a $220 million Series E led by Tiger Global Management with participation from Casdin Capital, ICONIQ Growth, Andreessen Horowitz and SVB Capital. [9]

Komodo Health lists its investors as Andreessen Horowitz, OAK HC/FT, Iconiq, IA Ventures, Felicis Ventures, Tiger Global, SVB Capital, McKesson and Casdin Capital. [11]